Vikramdeep Monga

2.8k total citations · 1 hit paper
69 papers, 2.2k citations indexed

About

Vikramdeep Monga is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Vikramdeep Monga has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 35 papers in Organic Chemistry and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Vikramdeep Monga's work include Synthesis and biological activity (23 papers), Synthesis and Biological Evaluation (10 papers) and Neuropeptides and Animal Physiology (9 papers). Vikramdeep Monga is often cited by papers focused on Synthesis and biological activity (23 papers), Synthesis and Biological Evaluation (10 papers) and Neuropeptides and Animal Physiology (9 papers). Vikramdeep Monga collaborates with scholars based in India, United States and Singapore. Vikramdeep Monga's co-authors include Gurpreet Singh, Punniyakoti T. Veeraveedu, Rahul Jain, Rahul Kumar Maurya, Bhupinder Kumar, Shalini Jaswal, Shubham Kumar, Navneet Kaur, Amit Nayyar and Sahil Sharma and has published in prestigious journals such as Journal of Biological Chemistry, Pharmacology & Therapeutics and Critical Reviews in Food Science and Nutrition.

In The Last Decade

Vikramdeep Monga

63 papers receiving 2.1k citations

Hit Papers

An insight into the medicinal perspective of synthetic an... 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An insight into the medicinal perspective of synthetic analogs of indole: A review
    2019 273 citations Punniyakoti T. Veeraveedu, Vikramdeep Monga et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikramdeep Monga India 27 1.3k 810 297 175 161 69 2.2k
Roberta Budriesi Italy 30 1.0k 0.8× 1.1k 1.3× 310 1.0× 140 0.8× 196 1.2× 154 2.7k
Zhe‐Shan Quan China 34 2.2k 1.7× 1.3k 1.7× 400 1.3× 218 1.2× 199 1.2× 161 3.4k
Valentina Onnis Italy 31 1.8k 1.4× 809 1.0× 524 1.8× 135 0.8× 105 0.7× 122 2.8k
Arianna Granese Italy 29 1.2k 0.9× 492 0.6× 559 1.9× 182 1.0× 94 0.6× 46 2.0k
Philippe Chavatte France 26 707 0.6× 1.2k 1.4× 504 1.7× 207 1.2× 280 1.7× 85 2.5k
Xiang‐Yang Ye China 25 711 0.6× 1.1k 1.4× 342 1.2× 129 0.7× 60 0.4× 79 2.4k
Bhupinder Kumar India 30 1.3k 1.0× 653 0.8× 520 1.8× 367 2.1× 92 0.6× 93 2.3k
Jacques H. Poupaert Belgium 29 1.2k 1.0× 1.0k 1.3× 339 1.1× 94 0.5× 291 1.8× 120 2.4k
Giovanni Lentini Italy 29 553 0.4× 1.2k 1.5× 227 0.8× 217 1.2× 254 1.6× 129 2.3k
Simone Bertini Italy 23 551 0.4× 775 1.0× 459 1.5× 155 0.9× 225 1.4× 82 1.7k

Countries citing papers authored by Vikramdeep Monga

Since Specialization
Citations

This map shows the geographic impact of Vikramdeep Monga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikramdeep Monga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikramdeep Monga more than expected).

Fields of papers citing papers by Vikramdeep Monga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikramdeep Monga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikramdeep Monga. The network helps show where Vikramdeep Monga may publish in the future.

Co-authorship network of co-authors of Vikramdeep Monga

This figure shows the co-authorship network connecting the top 25 collaborators of Vikramdeep Monga. A scholar is included among the top collaborators of Vikramdeep Monga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikramdeep Monga. Vikramdeep Monga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monga, Vikramdeep, et al.. (2025). Recent progress in the synthetic and medicinal perspective of imidazo[2,1- b ]thiazole derivatives. Future Medicinal Chemistry. 17(17). 2163–2177.
2.
Monga, Vikramdeep, et al.. (2025). Thiazolopyrimidine, a privileged scaffold: Recent updates on synthetic and pharmacological perspective in drug discovery. Archiv der Pharmazie. 358(3). e2400870–e2400870.
3.
Verma, Anita, et al.. (2025). Advances in the design, discovery, and optimization of aurora kinase inhibitors as anticancer agents. Expert Opinion on Drug Discovery. 20(4). 475–497. 1 indexed citations
4.
5.
6.
Singh, Gurpreet, et al.. (2025). Recent developments of pyrimidine appended HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorganic Chemistry. 157. 108273–108273. 1 indexed citations
7.
8.
Monga, Vikramdeep, et al.. (2024). Recent Advances in the Synthesis and Medicinal Perspective of Pyrazole-Based α-Amylase Inhibitors as Antidiabetic Agents. Future Medicinal Chemistry. 16(2). 173–195. 7 indexed citations
9.
Singh, Gurpreet, Rajveer Singh, Vikramdeep Monga, & Sidharth Mehan. (2024). 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation. European Journal of Medicinal Chemistry. 266. 116139–116139. 13 indexed citations
10.
Singh, Gurpreet, Rajveer Singh, Vikramdeep Monga, & Sidharth Mehan. (2024). Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation. RSC Medicinal Chemistry. 15(8). 2826–2854. 7 indexed citations
11.
Singh, Gurpreet & Vikramdeep Monga. (2023). Peptide Nucleic Acids: Recent Developments in the Synthesis and Backbone Modifications. Bioorganic Chemistry. 141. 106860–106860. 11 indexed citations
12.
Singh, Yogesh, et al.. (2023). Molecular docking, 3D-QSAR and simulation studies for identifying pharmacophoric features of indole derivatives as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5) inhibitors. Journal of Biomolecular Structure and Dynamics. 41(22). 12668–12685. 8 indexed citations
13.
Bhatti, Jasvinder Singh, et al.. (2023). Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds. European Journal of Medicinal Chemistry. 259. 115699–115699. 47 indexed citations
14.
Singh, Gurpreet, et al.. (2022). The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review. Archiv der Pharmazie. 355(9). e2100517–e2100517. 24 indexed citations
15.
Singh, Gurpreet, et al.. (2021). Adenosine receptor antagonists: Recent advances and therapeutic perspective. European Journal of Medicinal Chemistry. 227. 113907–113907. 46 indexed citations
16.
Singh, Gurpreet, et al.. (2021). Aurora kinase inhibitors as potential anticancer agents: Recent advances. European Journal of Medicinal Chemistry. 221. 113495–113495. 47 indexed citations
17.
Arora, Nidhi, et al.. (2019). Recent advances in the synthetic and medicinal perspective of quinolones: A review. Bioorganic Chemistry. 92. 103291–103291. 117 indexed citations
18.
19.
Kaur, Navneet, Vikramdeep Monga, Xinping Lu, Marvin C. Gershengorn, & Rahul Jain. (2006). Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1. Bioorganic & Medicinal Chemistry. 15(1). 433–443. 28 indexed citations
20.
Kaur, Navneet, Vikramdeep Monga, J.S. Josan, et al.. (2006). Synthesis, receptor binding, and activation studies of N(1)-alkyl-l-histidine containing thyrotropin-releasing hormone (TRH) analogues. Bioorganic & Medicinal Chemistry. 14(17). 5981–5988. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Budriesi Breakdown of academic impact, for papers by Zhe‐Shan Quan Breakdown of academic impact, for papers by Valentina Onnis Breakdown of academic impact, for papers by Arianna Granese Breakdown of academic impact, for papers by Philippe Chavatte Breakdown of academic impact, for papers by Xiang‐Yang Ye Breakdown of academic impact, for papers by Bhupinder Kumar Breakdown of academic impact, for papers by Jacques H. Poupaert Breakdown of academic impact, for papers by Giovanni Lentini Breakdown of academic impact, for papers by Simone Bertini
Rankless by CCL
2026